Pitch your innovation

The call for pitches is closed.

For abstracts on technologies providing solutions in the field of infectious diseases in livestock:

STAR-IDAZ IRC will sponsor (travel, accommodation and full pass up to a total max. of € 3,500 per selected pitch) for two scientists to present their innovation at the DIAH conference. The sponsored innovations should have a demonstrable impact on at least one of the STAR-IDAZ IRC priority topics and will be selected by the Advisory Committee. Early as well as advanced career scientists from outside of Europe are specifically encouraged to apply.

Emerging Technologies

On Wednesday, 7 February 2024, the selected pitches for the innovation spotlight will present their case.

On the programme:

  • Genome-wide engineering of African swine fever virus using synthetic biology to accelerate vaccine development
    Sanjay Vashee - Professor and Rockville Campus Director at J. Craig Venter Institute

  • Lining the gut of dairy calves with bacteriophages protects them from Paratuberculosis
    Jeroen De Buck - Professor, Chair in Bacterial Diseases of Dairy Cattle at University of Calgary

  • Bacteriophage-derived endolysins are the next generation of antimicrobials to control streptococcal mammary gland infections in dairy cows
    Niels Vander Elst - Postdoctoral Researcher at Ghent University and KU Leuven

  • A novel recombinant vaccine for control of lung plague in cattle
    Paul Hodgson - Director of Operations at Vaccine and Infectious Disease Organization (VIDO)

  • MucoVac – Targeting to aminopeptidase N as a gateway through the gut barrier
    Hans Van der Weken - Postdoctoral Researcher at Ghent University

  • Towards prevention and improved management of canine diabetes : Utilising genetics in veterinary precision medicine
    Lucy Davison - Professor of Veterinary Clinical Genetics and MRC Clinician Scientist Fellow at Royal Veterinary College

Emerging Start-ups

On Thursday, 8 February 2024, the selected pitches for the innovation spotlight will present their case.

On the programme:

  • VHH based solution for treating complex diseases in animal health
    Charles Owen - CEO at 272 BIO

  • Synocure, biomedical nanotechnology for the treatment of equine lameness
    Lucas Decuypere - CEO at Allegro

  • Challenging the status quo: An antimicrobial alternative with a bioactive polymer for bovine health
    Jelena Suran - CEO at Apiotix Technologies

  • Novel treatment of urothelial cancer of the bladder in dogs
    Annelies Bogaerts - CDO at Benno Therapeutics

  • Soundsafe Care – For a “safe & sound” veterinary care
    Andrea Mariani - CEO at Soundsafe Care

  • Faster, simpler, and cheaper facilities for RNA development and production with Ntensify technology

  • Lionel Malbec - Product Manager at Quantoom Biosciences